Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2012 17:36 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Management Changes

SAN DIEGO, Nov. 6, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Bassam Damaj, Ph.D., has resigned...
October 18, 2012 06:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Receives $2.5 Million Payment From Abbott Laboratories for Vitaros(R) in Canada

SAN DIEGO, Oct. 18, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that it received a $2.5 million...
October 01, 2012 06:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Intent to File NDS for MycoVa(TM) in Canada

SAN DIEGO, Oct. 1, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today its intent to file a New Drug...
September 25, 2012 09:58 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences CEO to Present at Sachs Annual Biotech in Europe Investor Forum

SAN DIEGO, Sept. 25, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Bassam Damaj, Ph.D., President...
September 17, 2012 15:20 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Publication in Journal of Pharmaceutics and Drug Delivery Research

SAN DIEGO, Sept. 17, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today publication in the current issue of...
September 13, 2012 06:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences' Wholly-Owned Subsidiary NexMed (U.S.A.) and Takeda Pharmaceuticals International GmbH Sign Exclusive License Agreement to Market Vitaros(R) in the United Kingdom

SAN DIEGO and ZURICH, Switzerland, Sept. 13, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI) and Takeda Pharmaceuticals International GmbH jointly announced today that they have...
August 22, 2012 15:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences' CEO to Present at the Stifel Nicolaus 2012 Healthcare Conference

SAN DIEGO, Aug. 22, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Bassam Damaj, Ph.D., President...
August 20, 2012 09:42 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Podium Presentation of Vitaros(R) Clinical Data at 2012 World Meeting on Sexual Medicine

SAN DIEGO, Aug. 20, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (www.apricusbio.com) today announced a podium presentation entitled, "Nine months treatment with...
August 16, 2012 09:12 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Podium Presentation of Femprox(R) Phase III Clinical Data at 2012 World Meeting on Sexual Medicine

SAN DIEGO, Aug. 16, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (www.apricusbio.com) today announced a podium presentation titled, "Updated analyses of a...
August 08, 2012 09:07 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Second Quarter 2012 Financial Results Conference Call and Provides Corporate Update

SAN DIEGO, Aug. 8, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) announced today that it will hold a conference call to discuss its second quarter...